About ImmGenics Pharmaceuticals
ImmGenics Pharmaceuticals is a company based in Vancouver (Canada) founded in 1993 was acquired by Abgenix in September 2000. ImmGenics Pharmaceuticals operates in a competitive market with competitors including GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.
- Headquarter Vancouver, Canada
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of ImmGenics Pharmaceuticals
Investors in ImmGenics Pharmaceuticals
ImmGenics Pharmaceuticals has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Nomura and Abgenix.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Diversified asset management services are offered globally by the firm.
|
Locked | Locked | Locked | |
|
Fully human therapeutic antibodies for cancer and inflammation are discovered.
|
Locked | Locked | Locked |
Investor details for ImmGenics Pharmaceuticals
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by ImmGenics Pharmaceuticals
Investment portfolio details for ImmGenics Pharmaceuticals
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - ImmGenics Pharmaceuticals
Detailed financials for ImmGenics Pharmaceuticals
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Immgenics Pharmaceuticals Comparisons
Peer comparison for ImmGenics Pharmaceuticals
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of ImmGenics Pharmaceuticals
ImmGenics Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of pharmaceuticals and vaccines for various therapeutic areas
|
|
| Locked | Locked | Locked |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| Locked | Locked | Locked |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| Locked | Locked | Locked |
Yeast cells are genetically engineered to produce medicinal products.
|
|
| Locked | Locked | Locked |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| Locked | Locked | Locked |
CRISPR-engineered cell and gene therapies are developed for research applications.
|
Detailed competitors of ImmGenics Pharmaceuticals
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Immgenics Pharmaceuticals
Complete news archive for ImmGenics Pharmaceuticals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ImmGenics Pharmaceuticals
ImmGenics Pharmaceuticals was founded in 1993 and raised its 1st funding round 7 years after it was founded.
ImmGenics Pharmaceuticals is headquartered in Vancouver, Canada. It is registered at Vancouver, British Columbia, Canada.
ImmGenics Pharmaceuticals was founded in 1993 in Vancouver, Canada, within the biotechnology sector. A proprietary lymphocyte antibody technology was created, by which B-cells are cultured directly and assayed over several days via a microplate-based throughput system. Greater numbers of antibodies can be screened for specific antigen targets as a result. Operations centered on advancing drug discovery processes until acquisition by Abgenix in November 2000.
ImmGenics Pharmaceuticals's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.